Chemotherapy-Induced Peripheral Neuropathy (CIPN) has long stood as one of the most debilitating side effects of cancer treatment, often forcing…
Read More
Fish Oil Supplements Fail to Prevent Cognitive Decline in Large-Scale Clinical Trial
For millions of Americans, the daily ritual of swallowing a fish oil supplement has become synonymous with proactive health maintenance.…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of clinical research is currently undergoing a structural transformation characterized by an unprecedented surge in data complexity. In…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
The global landscape of hepatitis C virus (HCV) management has shifted significantly in the past decade, moving from a era…
Read More
After decades of trial failures in chemotherapy-linked neuropathy, psilocybin shows promise in preventing it in mice
Chemotherapy-Induced Peripheral Neuropathy (CIPN) has long stood as one of the most stubborn and debilitating side effects in oncology. Characterized…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of modern drug development is currently undergoing a seismic shift, driven by an unprecedented explosion in data volume…
Read MoreAbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
The landscape of hepatitis C (HCV) management has undergone a profound shift, yet a stark disconnect remains between clinical efficacy…
Read MoreAfter decades of trial failures in chemotherapy-linked neuropathy, psilocybin shows promise in preventing it in mice
For millions of cancer survivors, the battle against malignancy does not end with the successful eradication of a tumor. Instead,…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of modern drug development is currently undergoing a radical structural transformation driven by the collision of two opposing…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
In the global effort to eradicate hepatitis C (HCV), clinical success has frequently collided with the sobering realities of public…
Read More
